Free Trial
NASDAQ:GNCA

Genocea Biosciences (GNCA) Stock Price, News & Analysis

Genocea Biosciences logo

About Genocea Biosciences Stock (NASDAQ:GNCA)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
83,499 shs
Market Capitalization
$6 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive GNCA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Genocea Biosciences and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GNCA Stock News Headlines

Genocea Biosciences Inc GNCAQ
BREAKING: The House just passed 3 pro-crypto bills!
THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. tc pixel
GNCAQ Genocea Biosciences, Inc.
Genocea Biosciences, Inc. (GNCA)
GRPN, GNCA and LAB among mid-day movers
Genocea Biosciences to shut down
See More Headlines

GNCA Stock Analysis - Frequently Asked Questions

Genocea Biosciences, Inc. (NASDAQ:GNCA) posted its quarterly earnings results on Wednesday, October, 27th. The biotechnology company reported ($0.05) EPS for the quarter, beating the consensus estimate of ($0.20) by $0.15. The biotechnology company earned $1.64 million during the quarter.

Shares of GNCA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Genocea Biosciences investors own include Hawkins (HWKN), Xtrackers California Municipal Bond ETF (CA), Endologix (ELGX), Chipotle Mexican Grill (CMG), BlackRock (BLK), Aegean Marine Petroleum Network (ANW) and Micron Technology (MU).

Company Calendar

Last Earnings
10/27/2021
Today
8/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:GNCA
CIK
1457612
Employees
70
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.61)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$33.20 million
Net Margins
N/A
Pretax Margin
-1,946.15%
Return on Equity
-182.88%
Return on Assets
-62.76%

Debt

Debt-to-Equity Ratio
0.24
Current Ratio
1.35
Quick Ratio
1.35

Sales & Book Value

Annual Sales
$1.91 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.47 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
58,730,000
Free Float
57,788,000
Market Cap
$6 thousand
Optionable
Not Optionable
Beta
1.61

Social Links

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:GNCA) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners